Gomes M - Search Results

1

Influence of CYP3A4 genotypes in the outcome of serous ovarian cancer patients treated with first-line chemotherapy: implication of a CYP3A4 activity profile.

Assis J, Pereira D, Gomes M, Marques D, Marques I, Nogueira A, Catarino R, Medeiros R. Assis J, et al. Among authors: gomes m. Int J Clin Exp Med. 2013 Aug 1;6(7):552-61. Print 2013. Int J Clin Exp Med. 2013. PMID: 23936594 Free PMC article.

2

Improvement of a predictive model in ovarian cancer patients submitted to platinum-based chemotherapy: implications of a GST activity profile.

Pereira D, Assis J, Gomes M, Nogueira A, Medeiros R. Pereira D, et al. Among authors: gomes m. Eur J Clin Pharmacol. 2016 May;72(5):545-53. doi: 10.1007/s00228-016-2015-3. Epub 2016 Jan 23. Eur J Clin Pharmacol. 2016. PMID: 26803611

3

Cyclin D1 polymorphism in non-small cell lung cancer in a Portuguese population.

Catarino R, Coelho A, Nogueira A, Araújo A, Gomes M, Lopes C, Medeiros R. Catarino R, et al. Among authors: gomes m. Cancer Biomark. 2012;12(2):65-72. doi: 10.3233/CBM-130294. Cancer Biomark. 2012. PMID: 23396251

4

Influence of DNA repair RAD51 gene variants in overall survival of non-small cell lung cancer patients treated with first line chemotherapy.

Nogueira A, Catarino R, Coelho A, Araújo A, Gomes M, Medeiros R. Nogueira A, et al. Among authors: gomes m. Cancer Chemother Pharmacol. 2010 Aug;66(3):501-6. doi: 10.1007/s00280-009-1187-2. Epub 2009 Dec 4. Cancer Chemother Pharmacol. 2010. PMID: 19960343 Clinical Trial.

5

Prognostic significance of telomerase polymorphism in non-small cell lung cancer.

Catarino R, Araújo A, Coelho A, Gomes M, Nogueira A, Lopes C, Medeiros RM. Catarino R, et al. Among authors: gomes m. Clin Cancer Res. 2010 Jul 15;16(14):3706-12. doi: 10.1158/1078-0432.CCR-09-3030. Epub 2010 Jul 6. Clin Cancer Res. 2010. PMID: 20606038 Clinical Trial.

6

Influence of functional genetic polymorphism (-590C/T) in non-small cell lung cancer (NSCLC) development: the paradoxal role of IL-4.

Gomes M, Coelho A, Araújo A, Teixeira AL, Catarino R, Medeiros R. Gomes M, et al. Gene. 2012 Aug 1;504(1):111-5. doi: 10.1016/j.gene.2012.05.008. Epub 2012 May 11. Gene. 2012. PMID: 22583827

7

Circulating DNA: diagnostic tool and predictive marker for overall survival of NSCLC patients.

Catarino R, Coelho A, Araújo A, Gomes M, Nogueira A, Lopes C, Medeiros R. Catarino R, et al. Among authors: gomes m. PLoS One. 2012;7(6):e38559. doi: 10.1371/journal.pone.0038559. Epub 2012 Jun 12. PLoS One. 2012. PMID: 22701665 Free PMC article.

8

Improvement of a predictive model of castration-resistant prostate cancer: functional genetic variants in TGFβ1 signaling pathway modulation.

Teixeira AL, Gomes M, Nogueira A, Azevedo AS, Assis J, Dias F, Santos JI, Lobo F, Morais A, Maurício J, Medeiros R. Teixeira AL, et al. Among authors: gomes m. PLoS One. 2013 Aug 9;8(8):e72419. doi: 10.1371/journal.pone.0072419. eCollection 2013. PLoS One. 2013. PMID: 23951322 Free PMC article.

9

Circulating Ang-2 mRNA expression levels: looking ahead to a new prognostic factor for NSCLC [corrected].

Coelho AL, Araújo A, Gomes M, Catarino R, Marques A, Medeiros R. Coelho AL, et al. Among authors: gomes m. PLoS One. 2014 Feb 28;9(2):e90009. doi: 10.1371/journal.pone.0090009. eCollection 2014. PLoS One. 2014. PMID: 24587185 Free PMC article.

10

Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development.

Santos JI, Teixeira AL, Dias F, Gomes M, Nogueira A, Assis J, Medeiros R. Santos JI, et al. Among authors: gomes m. Tumour Biol. 2014 Jul;35(7):6245-53. doi: 10.1007/s13277-014-1887-z. Epub 2014 Apr 25. Tumour Biol. 2014. PMID: 24763824 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,448 results

Search Page

Filters